Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block in Robotic Partial Nephrectomy
NCT02460640Completed
- Sponsor
- IRCCS Regina Elena National Cancer Institute
- Start
- May 2015
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by IRCCS Regina Elena National Cancer Institute. Primary endpoints: Morphine consumption 24 hr after surgery and Acute pain after surgery measured with Numerical Rating Scale at 24 hours. Started May 2015; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02460640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460640.